CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) Form 10-K Annual Reports
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CELZ
CIK: 1187953
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haynie & Company
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerBenjamin Brown
Audit LocationSalt Lake City, Utah, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D | 2026-10-01 | — | SCHEDULE 13D Filing | 0001477932-26-005959 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | FORM 4 | 0001477932-26-005811 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-24 | FORM 8-K | 0001477932-26-005805 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-28 | FORM 8-K | 0001477932-26-005329 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | FORM 10-Q | 0001477932-26-004779 | View SEC Doc Filr Page |
| 424B3 | 2026-08-03 | — | 424B3 | 0001477932-26-004674 | View SEC Doc Filr Page |
| EFFECT | 2026-07-31 | — | EFFECT Filing | 9999999995-26-002513 | View SEC Doc Filr Page |
| S-3 | 2026-07-24 | — | FORM S-3 | 0001477932-26-004498 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-14 | 2026-08-28 | DEF 14A | 0001477932-26-004302 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | FORM 8-K | 0001477932-26-004165 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-01 | 2026-07-01 | PRE 14A | 0001477932-26-004146 | View SEC Doc Filr Page |
| RW | 2026-06-30 | — | RW | 0001477932-26-004097 | View SEC Doc Filr Page |
| S-1/A | 2026-06-26 | — | FORM S-1/A | 0001477932-26-004044 | View SEC Doc Filr Page |
| S-1 | 2026-06-25 | — | FORM S-1 | 0001477932-26-004010 | View SEC Doc Filr Page |
| DRS | 2026-05-28 | — | DRS Filing | 0001477932-26-003466 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | FORM 10-Q | 0001477932-26-002893 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-24 | 2025-12-31 | FORM 10-K/A | 0001477932-26-002534 | View SEC Doc Filr Page |
| 10-K | 2026-03-20 | 2025-12-31 | FORM 10-K | 0001477932-26-001517 | View SEC Doc Filr Page |
| 8-K | 2025-12-31 | 2025-12-26 | FORM 8-K | 0001477932-25-009277 | View SEC Doc Filr Page |
| 8-K | 2025-12-19 | 2025-12-18 | FORM 8-K | 0001477932-25-009094 | View SEC Doc Filr Page |
| 424B3 | 2025-12-16 | — | 424B3 | 0001477932-25-008989 | View SEC Doc Filr Page |
| EFFECT | 2025-12-12 | — | EFFECT Filing | 9999999995-25-003706 | View SEC Doc Filr Page |
| CORRESP | 2025-12-09 | — | CORRESP Filing | 0001477932-25-008872 | View SEC Doc Filr Page |
| S-3 | 2025-11-21 | — | FORM S-3 | 0001477932-25-008553 | View SEC Doc Filr Page |
| DEF 14A | 2025-11-13 | 2025-12-26 | DEF 14A | 0001477932-25-008184 | View SEC Doc Filr Page |